Single cell antibody discovery using 'Islands of Automation

Success in gene and cell therapy has increased demand for plasmid DNA used to produce viral vectors, both in quantities for commercial products as well as the breadth of different vectors for the expanding number of programs in development.

Dr. Kristin Comella, Chief Science Officer of U.S. Stem Cell, Inc. a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the successful launch of an open, livestream webinar series designed to inform and educate the public on the benefits and applications of stem cell therapy.

Because of its reliability, sensitivity and low cost, PCR has become the backbone of modern diagnostics. In recent years, researchers have ingeniously capitalized on the fundamental nature of PCR through multiplexing reactions saving reagent costs, precious samples, and user time. Multiplexing has also enabled pathogen screening and genotyping for much larger numbers of targets, thereby improving the breadth and utility of diagnostics. However, while multiplexing reactions can be a boon to lab productivity, they are not without their pitfalls.

Bio-metrics authentication is fast replacing passwords as the choice of authentication technique on web and mobile applications. This webinar covers various bio-metric options, comparative benefits and emerging trends.